Menu

Featured News

Some of the leading stories and synthetic biology information from SynbiCITE

The SynbiCITE ‘4-Day MBA, More Business Acumen’ Course

The SynbiCITE ‘4-Day MBA: More Business Acumen’ Course, 8th-12th December 2019In 2015, 35% of employers in engineering and technology-based business s...

Read article

SynbiTECH 2020 - Register your interest

SynbiTECH will return to London on 6-7th July 2020!To be kept up to date on ticket sales and conference announcements please register your interest he...

Read article

SynbiTECH 2020

6th-7th July 2020

SynbiTECH 2020 is an international forum for experts engaged in synthetic biology investment, policymaking, science and research. The event will focus on key opportunities to build a multibillion-dollar synthetic biology industry and grow the bio-economy.

Taking place at the iconic QEII Centre, situated in the heart of London directly opposite Westminster Abbey, and less than five minutes' walk from Big Ben and the Thames

Register now

UK Synthetic Biology start-up survey 2017

The UK’s first survey of the Synthetic Biology industry following a year of significant progress.

SynbiCITE’s UK Synthetic Biology start-up survey 2017 will assess the current and potential size of the Synthetic Biology industry, looking closely at growth trends, company scale, the value of the sector, key stakeholders and the commercial impact it could have. The challenges facing the industry, such as funding and IP protection, regulatory issues and ethics will also be evaluated. The completed report will be available this summer.

SynbiCITE has created a globally renowned national resource of interacting partners from academia, industry and business across the UK to accelerate the commercialisation of world-class science and emerging technologies encompassed by synthetic biology into new products, tools, processes and services.

Download your copy here

Innovation, education & collaboration

Watch SynbiCITE's new film to get an insight into the potential that synthetic biology offers us all.

Synthetic biology is unlocking significant new opportunities for industries ranging from life sciences and specialty chemicals to bioenergy and waste remediation. By facilitating the creation of new tools and techniques, synbio has the potential to reshape many technologies to affect our lives positively and to reduce the impact that we have on our planet. Synbio is the engineering of biology and it’s already helping to make many businesses more effective, more productive and more environmentally friendly.

SynbiCITE has created a globally renowned national resource of interacting partners from academia, industry and business across the UK which accelerates the commercialisation of world-class science and the emerging technologies encompassed by synthetic biology and engineering biology into new products, tools, processes and services.

Discover more

Resources

SynbiCITE has a number of resources available to all our partners to use for the translation of their research into new products, tools and processes.

View our resources

We partner with some of the world’s most forward-thinking organisations

We support our partners through events and training programmes including problems-solutions brokerage meetings. We provide funding of development projects including seed funding of Proof of Concept projects and follow-on funding of longer, larger projects for the development of prototypes and taking these on to pilot production scale manufacturing.

View our network

Synthetic Biology community

Take a look at the active and interactive synthetic biology community. Join the conversation and get involved.
The SynbiCITE ‘4-Day MBA, More Business Acumen’ Course

The SynbiCITE ‘4-Day MBA: More Business Acumen’ Course, 8th-12th December 2019In 2015, 35% of employers in engineering and technology-based business s...

Read article
Prokarium secures £4.6m Wellcome funding for Entervax

Prokarium has announced an investment of £4.59 million from Wellcome to fund two clinical trials of its lead programme, Entervax.Follow this link for ...

Read article
Evonetix establishes scientific advisory board

CAMBRIDGE, UK, 20 December 2018 – EVONETIX LTD (‘Evonetix’), the Cambridge-based company pioneering an innovative approach to scalable and high-fideli...

Read article
Data-driven design and the opportunities it presents for biotech companies

Professor Paul Freemont, Co-Director of SynbiCITE, discussed the synthetic biology industry and the opportunities it is creating in a recently paper published in The Emerging Topics in Life Sciences entitled “Synthetic biology industry: data-driven design is creating new opportunities in biotechnology”.

Read article
SynbiTECH conference gets up close and personal with the synbio companies powering the uk bioeconomy

SynbiTECH 2019 is the only international conference focused on synthetic biology taking place in the UK in 2019, designed for senior business leaders from start-ups to multinationals, investors and policy makers.

Read blog article
Synthetic biology start-up Colorifix raises $3m Series A round to scale its revolutionary textile dyeing solution

Colorifix, a company that has developed the first commercial biological dyeing process, has raised a Series A round of $3 million from impact and stra...

Read article
The Cell Factories of the Future

Professor Paul Freemont, Co-Director of SynbiCITE, is the lead author of a recent article published by the World Economic Forum on this subject, entitled “How scientists are turning living cells into the tiny factories of the future”.

Read article
Book before March 29th to receive 20% discount*

Building a multibillion-dollar synthetic biology industry The Synthetic Biology conference taking place in 2019, in London, that is not to be missed....

Read article
Addressing Global Challenges

Expert insights from SynbiCITE's leadership on the role of synthetic biology in solving some of the most significant challenges currently faced by our society

Read article
SynbiTECH 2020 - Register your interest

SynbiTECH will return to London on 6-7th July 2020!To be kept up to date on ticket sales and conference announcements please register your interest he...

Read article
2018 Meeting on UK Synthetic Genomics

On the 17th September 2018, a one-day meeting entitled "Synthesising a Human Genome: What could go right? " was held at the Wellcome Trust in London...

Read blog article
Evonetix wins Best Emerging Synthetic Biology Company at the OBN Awards

London, UK, 12th October 2018 / Sciad Newswire / SynbiCITE would like to congratulate Evonetix on winning ‘Best Emerging Synthetic Biology Company’ at...

Read article